Study summary · 2025 · Evidence review
The economics of patient-reported mobile monitoring
Patient-reported mobile monitoring showed promising but uncertain economic value.
Summary by Vironix Health · Source review: November 11, 2026
How we select and interpret evidence
Original publication
Sean P Gavan; Katherine Payne; William G Dixon; Sabine N van der Veer; Alexander C T Tam; Nick Bansback
University of Manchester and NIHR Manchester Biomedical Research Centre; Providence Research Institute and University of British Columbia
npj Digital Medicine · Online: · Issue: 2025
Journal version of record. · Full text consulted.
What was studied
- Design
- Evidence review
- Population
- Adults with six types of long-term condition
- Sample
- 7 cost-effectiveness analyses
- Intervention
- Repeated self-reported responses on smartphones/tablets
- Comparator
- Relevant alternative care strategies
- Follow-up
- Trial and model horizons varied
- Review search cutoff
- 2024-11
- Setting
- Multiple countries
Methods
Systematic appraisal of full economic evaluations.
Findings
Six of seven base-case analyses favored cost-effectiveness, but decision uncertainty was substantial.
Limitations
Only seven analyses qualified. Cost measurement differed, and results were specific to each health system. Measurements requiring additional devices, such as BP cuffs or spirometers, and passive wearable monitoring were excluded.
What this means for care delivery
Use this for symptom-monitoring economics; it cannot directly validate connected BP-cuff programs or Medicare RPM margins.